Evidence map›Paper›PMID 35832493›Full record

ArticleFrontiers in toxicology2022

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System.

Arunima Sengupta, Nuria Roldan, Mirjam Kiener, Laurène Froment, Giulia Raggi, Theo Imler, Lea de Maddalena, Aude Rapet, Tobias May, Patrick Carius and 8 more

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Targeting the epithelium in pulmonary fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Arunima SenguptaOrgans-on-Chip Technologies, ARTORG Center for Biomedical Engineering, University of Bern, Bern, Switzerland.
Nuria RoldanAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Mirjam KienerDepartment of Pulmonary Medicine, Inselspital, Bern University Hospital, Bern, Switzerland.
Laurène FromentAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Giulia RaggiAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Theo ImlerAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Lea de MaddalenaAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Aude RapetAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Tobias MayInSCREENeX GmbH, Braunschweig, Germany.
Patrick CariusDepartment of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Nicole Schneider-DaumDepartment of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Claus-Michael LehrDepartment of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Marianna Kruithof-de JulioDepartment for BioMedical Research DBMR, Urology Research Laboratory, University of Bern, Bern, Switzerland.
Thomas GeiserDepartment of Pulmonary Medicine, Inselspital, Bern University Hospital, Bern, Switzerland.
Thomas Michael MartiDepartment of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland.
Janick D StuckiAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Nina HobiAlveolix AG, Swiss Organs-on-Chip Innovation, Bern, Switzerland.
Olivier T GuenatOrgans-on-Chip Technologies, ARTORG Center for Biomedical Engineering, University of Bern, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evaluation of inhalation toxicity, drug safety and efficacy assessment, as well as the investigation of complex disease pathomechanisms, are increasingly relying on

Indexed as

alveolar epithelial cellsAT1 and AT2cyclic stretchdistal lunglung inflammationlung-on-a-chiplung toxicitySARS-CoV-2

Identifiers

PMID35832493
PMCPMC9272139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.